TIMM10 Antibody

What is TIMM10 and why is it important in mitochondrial research?

TIMM10 (Translocase of Inner Mitochondrial Membrane 10) is a critical component of mitochondrial protein import machinery. It functions as a mitochondrial intermembrane chaperone that participates in the import and insertion of multi-pass transmembrane proteins into the mitochondrial inner membrane . The human version has a canonical amino acid length of 90 residues and a protein mass of 10.3 kilodaltons .

TIMM10 plays several important roles:

• Facilitates the transfer of beta-barrel precursors from the TOM complex to the sorting and assembly machinery (SAM complex) of the outer membrane

• Acts as a chaperone-like protein that protects hydrophobic precursors from aggregation

• Guides precursor proteins through the mitochondrial intermembrane space

Understanding TIMM10 function is crucial for research into mitochondrial biogenesis, protein trafficking, and related disorders.

What key applications are TIMM10 antibodies used for in research?

TIMM10 antibodies are versatile research tools with multiple validated applications:

Different antibodies show reactivity with various species including human, mouse, rat, and others depending on the specific antibody .

How should I select the most appropriate TIMM10 antibody for my experimental needs?

Selection of the optimal TIMM10 antibody requires consideration of several key factors:

• Species reactivity: Ensure the antibody reacts with your model organism. Some antibodies are species-specific (human-only), while others cross-react with multiple species (human/mouse/rat) .

• Application compatibility: Verify the antibody is validated for your intended application. For example:

  • For Western blot: Most TIMM10 antibodies work well (observed at ~10 kDa)

  • For IHC: Check for specific validation in tissues of interest

• Epitope region: Consider which part of the protein you need to target:

  • Full-length (AA 1-90)

  • Central region (AA 21-49)

  • C-terminal region

• Clonality: Most TIMM10 antibodies are polyclonal, typically raised in rabbits

• Conjugation: Available options include:

  • Unconjugated (most common)

  • Biotin-conjugated

  • FITC-conjugated

  • HRP-conjugated

What critical controls should be included when using TIMM10 antibodies?

Robust experimental design requires appropriate controls:

Positive controls:

• Human heart and liver tissues show detectable TIMM10 expression

• Tissues with known high mitochondrial content

Negative controls:

• Primary antibody omission

• Isotype control (rabbit IgG)

• TIMM10 knockdown/knockout samples (if available)

Specificity controls:

• Pre-absorption with immunizing peptide

• Use of multiple antibodies targeting different epitopes

• Mass spectrometry validation for pull-down assays

What protocol optimizations are recommended for Western blot detection of TIMM10?

For optimal Western blot results with TIMM10 antibodies:

• Sample preparation:

  • Use mitochondria-enriched fractions for enhanced detection

  • Include protease inhibitors to prevent degradation

  • Denature samples at 95°C for 5 minutes in reducing sample buffer

• Gel selection:

  • Use 12-15% SDS-PAGE gels due to TIMM10's small size (10.3 kDa)

• Transfer conditions:

  • Optimize for small proteins: higher methanol concentration (20%)

  • Shorter transfer time or lower voltage to prevent small protein loss

• Antibody incubation:

  • Recommended dilutions: 1:500-1:2000

  • Incubate overnight at 4°C for best results

• Detection:

  • Enhanced chemiluminescence (ECL) systems are suitable

  • Expected band size: approximately 10 kDa

How should I optimize immunohistochemistry protocols for TIMM10 detection in tissue samples?

For effective TIMM10 immunohistochemical staining:

• Tissue preparation:

  • Formalin-fixed, paraffin-embedded (FFPE) sections

  • 4-5 μm section thickness recommended

• Antigen retrieval:

  • TE buffer (pH 9.0) is suggested as primary option

  • Alternative: citrate buffer (pH 6.0)

• Antibody dilution:

  • IHC dilution range: 1:20-1:200

  • Titrate for optimal signal-to-noise ratio

• Detection system:

  • DAB (3,3'-diaminobenzidine) for brightfield microscopy

  • Fluorescent secondary antibodies for immunofluorescence

• Positive control tissues:

  • Human colon cancer tissue has shown positive TIMM10 staining

How can I use TIMM10 antibodies to investigate mitochondrial dysfunction in disease models?

TIMM10 antibodies can be valuable tools for studying mitochondrial dysfunction:

• Protein expression analysis:

  • Quantify TIMM10 levels in disease vs. normal tissues

  • Correlate with other mitochondrial markers

• Protein-protein interaction studies:

  • Immunoprecipitation to investigate TIMM10 binding partners

  • Co-localization studies with TOM complex components

• Disease models:

  • TIMM10 has been associated with Mohr-Tranebjaerg Syndrome

  • Investigate alterations in mitochondrial protein import

• Experimental approaches:

  • Combine with mitochondrial fractionation

  • Use with respiratory chain complex antibodies

  • Pair with functional mitochondrial assays

What strategies can address conflicting results when working with different TIMM10 antibodies?

When facing discrepancies between TIMM10 antibody results:

• Epitope mapping:

  • Compare antibody recognition sites

  • Different antibodies may detect specific isoforms or post-translational modifications

• Validation approaches:

  • Use multiple antibodies targeting different epitopes

  • Confirm with genetic approaches (siRNA, CRISPR)

  • Employ mass spectrometry for protein identification

• Experimental design:

  • Include appropriate positive and negative controls

  • Standardize protocols across experiments

  • Document detailed methods for reproducibility

• Statistical analysis:

  • Use quantitative approaches to assess variability

  • Apply appropriate statistical tests to determine significance of differences

How can TIMM10 antibodies be integrated into experimental designs for causal mechanism studies?

For researchers investigating causal mechanisms involving TIMM10:

• Parallel design approach:

  • As described by Imai et al., two randomized experiments can be conducted in parallel :

    • First experiment: randomize only the treatment variable

    • Second experiment: randomize both treatment and mediator variables

  • This approach allows for improved identification of causal mechanisms

• Crossover design considerations:

  • Sequential assignment to two experiments

  • First assignment randomized, subsequent assignments determined based on treatment and mediator values

  • Can significantly improve identification power

• Analytical workflow:

  • For biotransformation studies involving antibodies like TIMM10, streamlined workflows can incorporate:

    • Creation of specific libraries for biotransformation analysis

    • High-resolution mass spectrometry for accurate identification

    • Integration of antibody sequence information for peak matching

• Quantification strategies:

  • LBA-LC-HRMS approaches for intact protein analysis

  • Surrogate peptide strategies with LC-MRM

  • Data analysis workflows that enable automated peak identification

What are the most common technical issues when working with TIMM10 antibodies and how can they be resolved?

Common challenges and solutions when working with TIMM10 antibodies:

When troubleshooting, consider the antibody's purification method and storage conditions. Most TIMM10 antibodies are affinity-purified and should be stored at -20°C in glycerol-containing buffers to maintain stability .

What quality control measures should be implemented when working with TIMM10 antibodies?

To ensure reliable results with TIMM10 antibodies:

• Antibody validation:

  • Verify specificity against recombinant TIMM10 protein

  • Test in known positive and negative controls

  • Consider using antibodies that have been validated in multiple applications

• Documentation:

  • Record antibody lot numbers

  • Document detailed experimental conditions

  • Maintain records of control experiments

• Storage and handling:

  • Aliquot antibodies to avoid repeated freeze-thaw cycles

  • Store according to manufacturer recommendations (-20°C)

  • Monitor expiration dates

• Regular performance testing:

  • Periodically test antibody on standard samples

  • Compare new lots to previous results

  • Update protocols as needed based on performance